SCHEMBL22247334

SCHEMBL22247334

CCC1CCC[C@@H](O[C@@H]2OC(CO)[C@H](O)C(O[C@@H](CC3CCCCC3)C(=O)N3CCC3)C2NC(=O)CN)C1O[C@@H]1OC(C)[C@@H](O)C(O)C1O

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SELE P16581 19/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22247354 0.93 SELE (0.64) SELE
SCHEMBL22247070 0.91 SELE (0.71) SELE
SCHEMBL26407465 0.85 SELE (0.70) SELE
SCHEMBL26408536 0.85 SELE (0.70) SELE
SCHEMBL18027906 0.85 SELE (0.71) SELE
SCHEMBL16661828 0.85 SELE (0.71) SELE
SCHEMBL21206341 0.84 SELE (0.70) SELE
SCHEMBL22821373 0.84 SELE (0.70) SELE
SCHEMBL21206345 0.84 SELE (0.67) SELE
SCHEMBL21206358 0.84 SELE (0.70) SELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150263-A1 SELECTIN OR GALECTIN ANTAGONISTS FOR TREATING CYTOKINE RELEASE SYNDROME AND CRS-INDUCED NEUROTOXICITY MAGNANI JOHN L (US) 2020-07-23 — — WO disclosed
Send feedback